74 related articles for article (PubMed ID: 10412330)
1. Correlation between EGFR and c-erbB-2 oncoprotein status and response to neoadjuvant chemotherapy in cervical carcinoma.
Kim JW; Kim YT; Kim DK
Yonsei Med J; 1999 Jun; 40(3):207-14. PubMed ID: 10412330
[TBL] [Abstract][Full Text] [Related]
2. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
3. 'Quick course' neoadjuvant chemotherapy with cisplatin, bleomycin and vincristine in advanced cervical cancer.
Singh KC; Agarwal A; Agarwal S; Rajaram S; Goel N; Agarwal N
Gynecol Obstet Invest; 2004; 58(2):109-13. PubMed ID: 15192286
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
[TBL] [Abstract][Full Text] [Related]
5. Expression of retinoblastoma tumor suppressor gene protein, epidermal growth factor receptor, and c-erbB-2 oncoprotein in primary vaginal carcinomas.
Skomedal H; Kristensen G; Holm R
Gynecol Oncol; 1995 Dec; 59(3):379-83. PubMed ID: 8522259
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer.
Benedetti Panici P; Bellati F; Manci N; Pernice M; Plotti F; Di Donato V; Calcagno M; Zullo MA; Muzii L; Angioli R
Ann Surg Oncol; 2007 Sep; 14(9):2643-8. PubMed ID: 17562114
[TBL] [Abstract][Full Text] [Related]
7. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
10. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer.
Schippinger W; Dandachi N; Regitnig P; Hofmann G; Balic M; Neumann R; Samonigg H; Bauernhofer T
Am J Clin Pathol; 2007 Oct; 128(4):630-7. PubMed ID: 17875515
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant intra-arterial chemotherapy followed by total laparoscopic radical trachelectomy in stage IB1 cervical cancer.
Lu Q; Zhang Y; Wang S; Guo S; Guo H; Zhang Z; Liu C
Fertil Steril; 2014 Mar; 101(3):812-7. PubMed ID: 24439996
[TBL] [Abstract][Full Text] [Related]
14. Using MR imaging to predict and evaluate the response of invasive cervical carcinoma to systemic chemotherapy.
Amano M; Kato T; Amano Y; Kumazaki T
AJR Am J Roentgenol; 1998 Nov; 171(5):1335-9. PubMed ID: 9798875
[TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
17. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T
Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy.
Jin L; Shen Q; Ding S; Jiang W; Jiang L; Zhu X
Gynecol Oncol; 2012 Jul; 126(1):140-6. PubMed ID: 22487537
[TBL] [Abstract][Full Text] [Related]
20. c-erbB-2 oncoprotein and epidermal growth factor receptor in cervical lesions.
Lakshmi S; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Pathobiology; 1997; 65(3):163-8. PubMed ID: 9309783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
